Ultimele actualizari :
05/12/2025
Anticoagulant   Dalteparin sodium  
Injectabil
Stabilitatea in solutie Stabilitatea in amestec Factorii care influenteaza stabilitatea Compatibilitate Microunde Bibliografie pdf

Denumirea comerciala   Denumirea comerciala     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Dalpin India
Daltehep India
Daltepin India
Fragmin Australia, Belgia, Brazilia, Canada, Chilli, Columbia, Croatia, Danemarca, Ecuador, Egipt, Elvetia, Emiratele Arabe Unite, Finlanda, Germania, Grecia, India, Iran, Islanda, Luxemburg, Malaezia, Marea Britanie, Maroc, Mexic, Norvegia, noua Zeelandă, Olanda, Polonia, Portugalia, Romania, Slovenia, Spania, SUA, Suedia, Tunisia, Ungaria, Venezuela
Fragmine Franta
Bibliografie   Injectabil   Bibliografie : Dalteparin sodium  
tip publicare
1624 ziar Louie S, Chin A, Gill MA.
Activity of dalteparin sodium in polypropylene syringes.
Am J Health-Syst Pharm 2000 ; 57: 760-762.
1873 ziar Laposata M, Johnson SM.
Assessment of the stability of dalteparin sodium in prepared syringes for up to thirty days/ In vitro study.
Clin Ther 2003 ; 25: 1219-1224.
2268 ziar Goldenberg NA, Jacobson L, Hthaway H, Tripputi M, Primeaux J, Child J.
AntiXa stability of diluted dalteparin for pediatric use.
Ann Pharmacotherapy 2008 ; 42, 4: 511-515.
3643 Laborator Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics
Sanofi 2015
4031 ziar Kirkham K, Munson J, McCluskey S, Graner K.
Stability of Dalteparin 1,000 Unit/mL in 0.9% Sodium Chloride for Injection in Polypropylene Syringes.
Int J Pharm Compound 2017 ;21 , 5 : 426-429
4976 Laborator FRAGMINE 10 000 U.I. anti-Xa/0,4 mL, solution injectable en seringue pré-remplie - Résumé des caractéristiques du produit.
PFIZER HOLDING FRANCE 2024

  Mentions Légales